Zurovac D

Malaria drug shortages in Kenya: a major failure to provide access to effective treatment.Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, Goodman CA, Zurovac D, Snow RW
Am J Trop Med Hyg, (2009). 80:737-8

Malaria misdiagnosis in Uganda--implications for policy change.Nankabirwa J, Zurovac D, Njogu JN, Rwakimari JB, Counihan H, Snow RW, Tibenderana JK
Malar J, (2009). 8:66

Health facility and health worker readiness to deliver new national treatment policy for malaria in Kenya.Njogu J, Akhwale W, Hamer DH, Zurovac D
East Afr Med J, (2008). 85:213-21

Malaria case-management under artemether-lumefantrine treatment policy in Uganda.Zurovac D, Tibenderana JK, Nankabirwa J, Ssekitooleko J, Njogu JN, Rwakimari JB, Meek S, Talisuna A, Snow RW
Malar J, (2008). 7:181

Modeling the financial and clinical implications of malaria rapid diagnostic tests in the case-management of older children and adults in Kenya.Zurovac D, Larson BA, Skarbinski J, Slutsker L, Snow RW, Hamel MJ
Am J Trop Med Hyg, (2008). 78:884-91

Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya.Zurovac D, Njogu J, Akhwale W, Hamer DH, Larson BA, Snow RW
Trop Med Int Health, (2008). 13:784-7

Translation of artemether-lumefantrine treatment policy into paediatric clinical practice: an early experience from Kenya.Zurovac D, Njogu J, Akhwale W, Hamer DH, Snow RW
Trop Med Int Health, (2008). 13:99-107

Why don't health workers prescribe ACT? A qualitative study of factors affecting the prescription of artemether-lumefantrine.Wasunna B, Zurovac D, Goodman CA, Snow RW
Malar J, (2008). 7:29

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya.Amin AA, Zurovac D, Kangwana BB, Greenfield J, Otieno DN, Akhwale WS, Snow RW
Malar J, (2007). 6:72

Improved diagnostic testing and malaria treatment practices in Zambia.Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda P, Sipilinyambe N, Simon JL, Snow RW
JAMA, (2007). 297:2227-31

Paediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study.Zurovac D, Ndhlovu M, Sipilanyambe N, Chanda P, Hamer DH, Simon JL, Snow RW
Malar J, (2007). 6:31

The financial and clinical implications of adult malaria diagnosis using microscopy in Kenya.Zurovac D, Larson BA, Akhwale W, Snow RW
Trop Med Int Health, (2006). 11:1185-94

Quality of treatment for febrile illness among children at outpatient facilities in sub-Saharan Africa.Zurovac D, Rowe AK
Ann Trop Med Parasitol, (2006). 100:283-96

Microscopy and outpatient malaria case management among older children and adults in Kenya.Zurovac D, Midia B, Ochola SA, English M, Snow RW
Trop Med Int Health, (2006). 11:432-40

Wealth, mother's education and physical access as determinants of retail sector net use in rural Kenya.Noor AM, Omumbo JA, Amin AA, Zurovac D, Snow RW
Malar J, (2006). 5:5

Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study.Zurovac D, Ndhlovu M, Rowe AK, Hamer DH, Thea DM, Snow RW
BMJ, (2005). 331:734

The quality of sulfadoxine-pyrimethamine prescriptions, counselling and drug-dispensing practices, for children in Kenya.Zurovac D, Ochola SA, Midia B, Snow RW
Ann Trop Med Parasitol, (2005). 99:321-4

Predictors of the quality of health worker treatment practices for uncomplicated malaria at government health facilities in Kenya.Zurovac D, Rowe AK, Ochola SA, Noor AM, Midia B, English M, Snow RW
Int J Epidemiol, (2004). 33:1080-91

Empirical modelling of government health service use by children with fevers in Kenya.Gething PW, Noor AM, Zurovac D, Atkinson PM, Hay SI, Nixon MS, Snow RW
Acta Trop, (2004). 91:227-37

Defining equity in physical access to clinical services using geographical information systems as part of malaria planning and monitoring in Kenya.Noor AM, Zurovac D, Hay SI, Ochola SA, Snow RW
Trop Med Int Health, (2003). 8:917-26